Associated Papers
Cross-β helical filaments of Tau and TMEM106B in Gray and White Matter of Multiple System Tauopathy with presenile Dementia.
Hoq MR et al.
Biorxiv : the Preprint Server for Biology, 2023
TREM2 Gene Compound Heterozygosity in Neurodegenerative Disorders.
Berdyński M et al.
Journal of Alzheimer's Disease : Jad, 2022
36031890 (PubMed )
Supplement: sj-xlsx-2-alz-10.3233_jad-220210.xlsx › Robocza
Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration.
Lee EB et al.
Acta Neuropathologica, 2017
TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
Jun MH et al.
Molecular Brain, 2015
TMEM106B a novel risk factor for frontotemporal lobar degeneration.
van der Zee J et al.
Journal of Molecular Neuroscience : Mn, 2011
Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis.
Rollinson S et al.
Neurobiology of Aging, 2011
TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort.
van der Zee J et al.
Brain : a Journal of Neurology, 2011
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
Finch N et al.
Neurology, 2011
Select a paper to view details